Jay Vreeland's Contact Details

Jay Vreeland's Company Details

Compumedics USA, LLC

Charlotte, North Carolina, United States • 51 - 200 Employees
Medical Devices

Compumedics, founded in 1987, is a global leader in the design & manufacture of innovative diagnostic technologies for sleep disorders, neurophysiology & cardiology.In 1987, Compumedics established Asia Pacific's first fully computerised sleep lab and holds 80% share of the Australian sleep-diagnostic market, and has a major & rapidly growing presence in the US, European & Asian markets for its sleep, neurological, & Doppler blood flow diagnostic monitoring devices.In 1995, the company was selected to supply equipment to the US Sleep Heart Health Study, the world's largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia & offices in the US & Europe, the products are distributed in over 50 countries. Achievements include : 1998 Australian Exporter of the Year2000 Listed on the Australian Stock Exchange2002 Acquired US-based Neuroscan, the world's leading supplier of instruments for brain research. Neuroscan holds about 90% of the USA market for brain research products2003 Frost & Sullivan Award for Market Expansion Strategy2004 Acquired German-based DWL Elektronishe GmbH2006 Frost & Sullivan Technology Leadership award for the innovative Somté2007 Victorian Manufacturing Hall of Fame2008 The DWL division received the top 100 German Innovation award2009 Design award for its Grael™ PSG/EEG premium lab solution2010 Recognised as Australia's top 100 health innovators2011 Established direct presence in France, awarded several significant USA contracts to supply preeminent USA customers with NeuvoLTM EEG2012 Celebrated 25 year silver jubilee anniversary ,CURRY7 and Neuvo 512 LTM EEG system released2013 Equity issued to Beijing Bestmed, its long-term partner in China2014 Released Upgrade to the world leading diagnostics software platform for Sleep and EEG, ProFusion2015 Core business strengthens and returns to strong operating profitability